268 related articles for article (PubMed ID: 16716165)
21. Autologous cultured melanocytes in vitiligo treatment.
Czajkowski R; Placek W; Drewa T; Kowaliszyn B; Sir J; Weiss W
Dermatol Surg; 2007 Sep; 33(9):1027-36; discussion 1035-6. PubMed ID: 17760593
[TBL] [Abstract][Full Text] [Related]
22. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
23. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic effectiveness of psoralen-UV-A bath therapy in psoriasis].
Rodríguez-Granados MT; Pereira-Rodríguez MJ; Vázquez-Vizoso FL
Actas Dermosifiliogr; 2009 Apr; 100(3):212-21. PubMed ID: 19457307
[TBL] [Abstract][Full Text] [Related]
25. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
Akman A; Dicle O; Yilmaz F; Coskun M; Yilmaz E
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):123-7. PubMed ID: 18477130
[TBL] [Abstract][Full Text] [Related]
26. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
28. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
Hamzavi I; Jain H; McLean D; Shapiro J; Zeng H; Lui H
Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
[TBL] [Abstract][Full Text] [Related]
29. Photochemotherapy in psoriasis and other skin diseases.
Adrian RM
Am Fam Physician; 1981 May; 23(5):95-100. PubMed ID: 7234635
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
31. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
Zailaie MZ
Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
[TBL] [Abstract][Full Text] [Related]
32. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
El Mofty M; Mostafa W; Esmat S; Youssef R; Azzam O; Hunter N; El Hanafi G; Fawzi M
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
[TBL] [Abstract][Full Text] [Related]
33. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
Lee Y; Seo YJ; Lee JH; Park JK
Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
[TBL] [Abstract][Full Text] [Related]
34. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
35. Patterns of repigmentation in two cases of hypopigmented type of vitiligo.
Anbar TS; El-Sawy AE; Attia SK; Moftah NH; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):156-8. PubMed ID: 19438996
[TBL] [Abstract][Full Text] [Related]
36. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial.
El Mofty M; Bosseila M; Mashaly HM; Gawdat H; Makaly H
Clin Exp Dermatol; 2013 Dec; 38(8):830-5. PubMed ID: 23551324
[TBL] [Abstract][Full Text] [Related]
37. Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial.
Schiener R; Brockow T; Franke A; Salzer B; Peter RU; Resch KL
Arch Dermatol; 2007 May; 143(5):586-96. PubMed ID: 17519218
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema.
Adişen E; Karaca F; Oztaş M; Gürer MA
Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241
[No Abstract] [Full Text] [Related]
39. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo.
Zailaie MZ
Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818
[TBL] [Abstract][Full Text] [Related]
40. Repair efficiency and PUVA therapeutic response variation in patients with vitiligo.
Tippisetty S; Goudi D; Mohammed AW; Jahan P
Toxicol In Vitro; 2013 Feb; 27(1):438-40. PubMed ID: 22921987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
